Seagen

Seagen company information, Employees & Contact Information

Explore related pages

Related company profiles:

Our technology network is built to observe and assess water spaces to understand issues, highlight opportunities and establish baseline data. We respond with our robots, by removing pollutants and adding infrastructure to grow beneficial species, like seaweed. We then repeat the process to ensure a continuous and measured response. Observe. Assess. Respond. Repeat ∞ SeaGen. Blue tech for a blue planet.

Company Details

Employees
17
Founded
-
Address
Paignton , Exeter, Gb
Industry
Technology, Information And Internet
HQ
Paignton , Exeter
Looking for a particular Seagen employee's phone or email?

Seagen Questions

News

Pfizer lays off 100 workers at former Seagen HQ in Seattle area - Fierce Pharma

Pfizer lays off 100 workers at former Seagen HQ in Seattle area Fierce Pharma

Seagen Acquisition: Key Details, Impact, and What Comes Next - sunsethq.com

Seagen Acquisition: Key Details, Impact, and What Comes Next sunsethq.com

Pfizer shuffles its deck post-Seagen | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Pfizer shuffles its deck post-Seagen | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

After Pfizer deal, former Seagen CEO returns to lead oncology startup - BioPharma Dive

After Pfizer deal, former Seagen CEO returns to lead oncology startup BioPharma Dive

Seagen filing details M&A negotiations with several companies before $43B Pfizer deal - GeekWire

Seagen filing details M&A negotiations with several companies before $43B Pfizer deal GeekWire

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline - Labiotech.eu

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline Labiotech.eu

Pfizer (PFE) to Purchase Cancer Drugmaker Seagen (SGEN) for $43 Billion - Bloomberg

Pfizer (PFE) to Purchase Cancer Drugmaker Seagen (SGEN) for $43 Billion Bloomberg

Pfizer Wins Seagen Sweepstakes with $43B Bid - BioSpace

Pfizer Wins Seagen Sweepstakes with $43B Bid BioSpace

Pfizer looks past COVID with $43 bln deal for cancer drug maker Seagen - Reuters

Pfizer looks past COVID with $43 bln deal for cancer drug maker Seagen Reuters

Novartis, Seagen veteran David Epstein is back, leading a new cancer startup - statnews.com

Novartis, Seagen veteran David Epstein is back, leading a new cancer startup statnews.com

WSJ News Exclusive | Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More - The Wall Street Journal

WSJ News Exclusive | Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More The Wall Street Journal

Pfizer snaps up Seagen for $43 billion - Chemical & Engineering News

Pfizer snaps up Seagen for $43 billion Chemical & Engineering News

Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows - CNBC

Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows CNBC

FTC asks Pfizer, Seagen for more information on proposed $43B merger - Fierce Pharma

FTC asks Pfizer, Seagen for more information on proposed $43B merger Fierce Pharma

Pfizer to buy Seagen in $43B cancer drug deal - BioPharma Dive

Pfizer to buy Seagen in $43B cancer drug deal BioPharma Dive

Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights - Reuters

Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights Reuters

Done deal: Pfizer completes $43B acquisition of Seagen, doubling its oncology pipeline - Fierce Pharma

Done deal: Pfizer completes $43B acquisition of Seagen, doubling its oncology pipeline Fierce Pharma

Pfizer stops buildout of $350M Seagen plant, leaving 120 workers' roles in question - Fierce Pharma

Pfizer stops buildout of $350M Seagen plant, leaving 120 workers' roles in question Fierce Pharma

Seagen plots new biologics plant to amp up antibody drug production - Fierce Pharma

Seagen plots new biologics plant to amp up antibody drug production Fierce Pharma

Seattle Genetics shortens name to Seagen, dropping local connection as it goes global - Fierce Pharma

Seattle Genetics shortens name to Seagen, dropping local connection as it goes global Fierce Pharma

In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off - Fierce Pharma

In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off Fierce Pharma

With $43B buyout, Pfizer sees cancer specialist Seagen as a 'goose' laying 'golden eggs' - Fierce Pharma

With $43B buyout, Pfizer sees cancer specialist Seagen as a 'goose' laying 'golden eggs' Fierce Pharma

Pfizer buys Seagen for $43B, boosts access to cancer drugs - AP News

Pfizer buys Seagen for $43B, boosts access to cancer drugs AP News

Merck and Seagen can't agree on a price for their rumored merger: Bloomberg - Fierce Pharma

Merck and Seagen can't agree on a price for their rumored merger: Bloomberg Fierce Pharma

Pfizer buys Bothell-based Seagen for $43B, boosts access to cancer drugs - The Seattle Times

Pfizer buys Bothell-based Seagen for $43B, boosts access to cancer drugs The Seattle Times

JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals - Fierce Pharma

JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals Fierce Pharma

Pfizer to close Seagen manufacturing plant in Seattle area following $43B acquisition - GeekWire

Pfizer to close Seagen manufacturing plant in Seattle area following $43B acquisition GeekWire

Deciding Between First-Line Treatment Options in BRAFV600E-Mutant Differentiated Thyroid Cancer - ASCO Daily News

Deciding Between First-Line Treatment Options in BRAFV600E-Mutant Differentiated Thyroid Cancer ASCO Daily News

Seagen and Astellas' Padcev, in Keytruda combo, delivers 'practice-changing' bladder cancer win - Fierce Pharma

Seagen and Astellas' Padcev, in Keytruda combo, delivers 'practice-changing' bladder cancer win Fierce Pharma

Pfizer Completes Acquisition of Seagen - Business Wire

Pfizer Completes Acquisition of Seagen Business Wire

Merck Has Good Reason to Buy a Cancer-Drug Biotech Seagen - Bloomberg

Merck Has Good Reason to Buy a Cancer-Drug Biotech Seagen Bloomberg

Pfizer’s $43B Seagen Buy Starts to Pay Off with Adcetris Phase III Data in DLBCL - BioSpace

Pfizer’s $43B Seagen Buy Starts to Pay Off with Adcetris Phase III Data in DLBCL BioSpace

Pfizer Agrees to Buy Seagen for $43 Billion - WSJ - The Wall Street Journal

Pfizer Agrees to Buy Seagen for $43 Billion - WSJ The Wall Street Journal

Pfizer puts 74 Swiss jobs on chopping block as it folds Seagen into its cancer operations - Fierce Pharma

Pfizer puts 74 Swiss jobs on chopping block as it folds Seagen into its cancer operations Fierce Pharma

Seagen, Merck put $1.6B ADC collab on the back burner citing 'emerging treatment landscape' - Fierce Biotech

Seagen, Merck put $1.6B ADC collab on the back burner citing 'emerging treatment landscape' Fierce Biotech

Does Stopping ICI Therapy Affect Survival in HNSCC? - Medscape

Does Stopping ICI Therapy Affect Survival in HNSCC? Medscape

In a year of turnover, Seagen doled out $126M to a trio of CEOs - Fierce Pharma

In a year of turnover, Seagen doled out $126M to a trio of CEOs Fierce Pharma

Pfizer Clears Final Regulatory Hurdles to Acquire Seagen Inc. - Pharmaceutical Executive

Pfizer Clears Final Regulatory Hurdles to Acquire Seagen Inc. Pharmaceutical Executive

Seagen names longtime Novartis exec as new CEO - statnews.com

Seagen names longtime Novartis exec as new CEO statnews.com

Are DACs the new ADCs? Seagen pays Nurix $60M to find out - Fierce Biotech

Are DACs the new ADCs? Seagen pays Nurix $60M to find out Fierce Biotech

US agency nixes Seagen patent, handing Daiichi Sankyo a win in long-running Enhertu entanglement - Fierce Pharma

US agency nixes Seagen patent, handing Daiichi Sankyo a win in long-running Enhertu entanglement Fierce Pharma

Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality - Fierce Biotech

Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality Fierce Biotech

Seagen Announces Plans to Expand Pacific Northwest Biomanufacturing Capacity to Support Growing Portfolio of Transformative Cancer Medicines - Business Wire

Seagen Announces Plans to Expand Pacific Northwest Biomanufacturing Capacity to Support Growing Portfolio of Transformative Cancer Medicines Business Wire

Pfizer to raise $31 billion for Seagen takeover in largest debt offering - Reuters

Pfizer to raise $31 billion for Seagen takeover in largest debt offering Reuters

Sanofi and Seagen: a Match Made in ADC Heaven - BioSpace

Sanofi and Seagen: a Match Made in ADC Heaven BioSpace

Seagen Strikes $2.6 Billion ADC Deal with China’s RemeGen - BioSpace

Seagen Strikes $2.6 Billion ADC Deal with China’s RemeGen BioSpace

Seagen CEO's arrest came during a hazy night of booze, sex and alleged violence: police report - Fierce Pharma

Seagen CEO's arrest came during a hazy night of booze, sex and alleged violence: police report Fierce Pharma

Pfizer to Close $43 Billion Seagen Acquisition After FTC Nod - Bloomberg

Pfizer to Close $43 Billion Seagen Acquisition After FTC Nod Bloomberg

Seagen, Genmab run 'CeMe' cervical cancer campaign amid Tivdak launch - Fierce Pharma

Seagen, Genmab run 'CeMe' cervical cancer campaign amid Tivdak launch Fierce Pharma

Pfizer pulls plug on mammoth Seagen pharma factory in Everett - The Seattle Times

Pfizer pulls plug on mammoth Seagen pharma factory in Everett The Seattle Times

Experts weigh in on Seagen's reported talks to be sold to Pfizer - The Business Journals

Experts weigh in on Seagen's reported talks to be sold to Pfizer The Business Journals

Seattle Genetics rebrands as Seagen as it expands business globally - MedCity News

Seattle Genetics rebrands as Seagen as it expands business globally MedCity News

Pfizer CFO reiterates Seagen closing expected later this year, early next year - Seeking Alpha

Pfizer CFO reiterates Seagen closing expected later this year, early next year Seeking Alpha

Seagen loses arbitration decision against Japanese drugmaker Daiichi Sankyo - The Business Journals

Seagen loses arbitration decision against Japanese drugmaker Daiichi Sankyo The Business Journals

Top Seagen Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant